Pharma Funds: Investment Potential
Dalal Street Investment Journal|December 18, 2023
Investors often assume that investing in the pharmaceutical sector is a safe bet given that its products and services are always in demand. However, investing in pharmaceutical funds requires a constant study of the market and the sector. Moreover, as they are more focused ona single sector, they offer no diversification benefit. Hence, even though they offer potentially higher risk, their underlying return is also on the higher end. Therefore, before you head towards investing in them, understand your risk profile, investment objectives and time horizon
Pharma Funds: Investment Potential

The Indian equity market, over the past few quarters, has witnessed substantial gains. This has resulted in heightened inflows into equity mutual funds. One important trend is sectoral or thematic mutual funds that are capturing investors’ attention, drawing in nearly ₹14,000 crore of inflows in the last five months. On a year-to-date (YTD) basis, sectoral or thematic funds had a cumulative net inflow of ₹22,871 crore.

This surge signifies a growing interest among investors willing to take on higher risks for potential rewards. Recent data from the Association of Mutual Funds in India (AMFI) highlights a shift in these funds’ fortunes, as indicated in the table below:

After a withdrawal of ₹169 crore in May, sectoral or thematic funds have consistently seen inflows since June 2023. In the month of October, thematic funds got a huge inflow of ₹3,896 crore, the second highest among equity categories. These sectoral or thematic funds focus on specific sectors or themes and are for investors comfortable with higher risk. In this article, we would be speaking about one of the standout performers of 2020 that experienced a downturn from August 2021 to March 2023. Nonetheless, it started to rebound at the onset of the financial year 2024. Indeed, we are talking about pharmaceutical funds.

The Nifty Pharma index surged from a low of 11,542.45 to a high of 16,279.10, resulting in impressive absolute returns of 41 per cent over a mere nine-month period. Concurrently, pharmaceutical funds delivered an average return of 38 per cent during this timeframe. Such a significant growth might instigate a fear of missing out (FOMO) among numerous investors.

This story is from the December 18, 2023 edition of Dalal Street Investment Journal.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.

This story is from the December 18, 2023 edition of Dalal Street Investment Journal.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.

MORE STORIES FROM DALAL STREET INVESTMENT JOURNALView All
All That Shines is Gold & Silver
Dalal Street Investment Journal

All That Shines is Gold & Silver

Precious metals gold and silver hold a special place when it comes to the investment journey of Indians. They help diversify investment risks and provide a hedge against market volatility, making them an essential component of a well-rounded investment strategy. Vaishnavi Chauhan explores the impact of precious metals on your portfolio.

time-read
7 mins  |
22 April, 2024
All You Wanted To Know About SIP
Dalal Street Investment Journal

All You Wanted To Know About SIP

Is rupee cost averaging effective across all market phases, including uptrends, consolidations and downtrends? You probably might not have observed its performance in each phase or may have exited investments upon seeing negative returns. Rakesh Deshmukh takes a closer look at the scenario

time-read
6 mins  |
22 April, 2024
When Is The Right Time To Sell Mutual Funds?
Dalal Street Investment Journal

When Is The Right Time To Sell Mutual Funds?

Imagine this scenario: You have diligently crafted your mutual fund portfolio, aligning each investment with your financial objectives and risk tolerance. All seems well until one day the market takes a steep dive, injecting uncertainty into your investment journey.

time-read
9 mins  |
22 April, 2024
Middle East Tension Disrupt Global Equities
Dalal Street Investment Journal

Middle East Tension Disrupt Global Equities

In the past fortnight, global stock markets experienced a rollercoaster ride, due to continued inflation concerns and escalating tensions in the Middle East. This confluence of events triggered a flight to safety, pushing investors towards safety assets

time-read
2 mins  |
22 April, 2024
Gold and Oil Stay Solid Amid Escalating Geopolitical Issue
Dalal Street Investment Journal

Gold and Oil Stay Solid Amid Escalating Geopolitical Issue

A boom in select commodities has threatened the central banks' inflation fight and interest rate cuts and now the gloves are coming off for them as they try to tame inflation

time-read
2 mins  |
22 April, 2024
India - A Cure For Pharma Outsourcing Woes?
Dalal Street Investment Journal

India - A Cure For Pharma Outsourcing Woes?

Eroom's Law, the grim corollary to Moore's Law, paints a concerning picture for the pharmaceutical industry.

time-read
9 mins  |
22 April, 2024
Infrastructure Sector Is It Reaching For The Skies?
Dalal Street Investment Journal

Infrastructure Sector Is It Reaching For The Skies?

With the upcoming Lok Sabha elections looming, many of us may be feeling the urge to invest in infrastructure stocks, hoping for a favourable impact on investments if a strong political mandate ensues. Mandar Wagh delves into the government's emphasis on infrastructural development, future growth triggers and the critical factor of fundamentals that must be taken into consideration before investing

time-read
7 mins  |
22 April, 2024
STABILITY ROCKED BY COMPETITION
Dalal Street Investment Journal

STABILITY ROCKED BY COMPETITION

While the company’s product portfolio and availability through various retail channels is undoubtedly impressive, the increasing competition posed by start-ups in the organised sector and the tendency of young consumers to try out various brands instead of displaying single brand loyalty is an issue of concern when it comes to future growth prospects

time-read
5 mins  |
22 April, 2024
Launches A Wide Range Of Air-Conditioners
Dalal Street Investment Journal

Launches A Wide Range Of Air-Conditioners

A leading name in the consumer electronics industry known for its innovative and cutting-edge technology, Cellecor Gadgets Limited is now stepping into the domain of air-conditioners, all set to make them available across India starting this month

time-read
3 mins  |
22 April, 2024
Domestic Markets Spin Into A Higher Orbit
Dalal Street Investment Journal

Domestic Markets Spin Into A Higher Orbit

The domestic market experienced a period of volatile trading sessions over the last two weeks, predominantly characterised by upward momentum. According to data released by the Ministry of Commerce and Industry, the index of eight core industries for February 2024 showed a growth of 6.7 per cent, an increase from 4.1 per cent in January 2024.

time-read
1 min  |
22 April, 2024